24 May 2013
Keywords: xenova, sees, first, nine, months, sales, slide
Article | 15 November 2004
UK biopharmaceutical firm Xenova Group has reported the initiation of patient-recruitment for Phase III clinical studies of its most advanced
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 November 2004
8 November 2004
© 2013 thepharmaletter.com